Avinger, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Avinger, Inc. | AVGR - NASDAQ |
$12.00-$14.00 |
$13.00 |
$13.15 | 5 million | 1/30/2015 |
Canaccord Genuity, Cowen & Co.
|
Co-Manager(s): Oppenheimer & Co., BTIG, Stephens Inc. |
Health Care |
Filing(s): Filed 2014-12-30 Terms Added 2015-01-20
|
For IPO Boutique's "scale of 1 to 5" BUY rating on Avinger, Inc., and our comprehensive analysis, click "Buy Market Research".
Avinger, Inc. Quote & Chart - Click for current quote -
AVGR
About Avinger, Inc. (adapted from Avinger, Inc. prospectus):
They are a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease, or PAD.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "AVGR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved